• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . A systematic review of using population-level human mobility data to understand SARS-CoV-2 transmission

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Dec 3;15(1):10504.
doi: 10.1038/s41467-024-54895-7. A systematic review of using population-level human mobility data to understand SARS-CoV-2 transmission

Natalya Kostandova[SUP] #[/SUP][SUP] 1 [/SUP], Catherine Schluth[SUP] #[/SUP][SUP] 2 [/SUP], Rohan Arambepola[SUP] 2 [/SUP], Fatumah Atuhaire[SUP] 3 [/SUP], Sophie Bérubé[SUP] 2 [/SUP], Taylor Chin[SUP] 4 [/SUP], Eimear Cleary[SUP] 3 [/SUP], Oscar Cortes-Azuero[SUP] 5 [/SUP], Bernardo García-Carreras[SUP] 6 [/SUP], Kyra H Grantz[SUP] 2 [/SUP], Matt D T Hitchings[SUP] 7 8 [/SUP], Angkana T Huang[SUP] 5 6 [/SUP], Nishant Kishore[SUP] 9 [/SUP], Shengjie Lai[SUP] 3 [/SUP], Sophie L Larsen[SUP] 10 [/SUP], Stacie Loisate[SUP] 2 [/SUP], Pamela Martinez[SUP] 11 12 [/SUP], Hannah R Meredith[SUP] 2 [/SUP], Ritika Purbey[SUP] 13 [/SUP], Tanjona Ramiadantsoa[SUP] 14 15 [/SUP], Jonathan Read[SUP] 16 [/SUP], Benjamin L Rice[SUP] 17 [/SUP], Lori Rosman[SUP] 18 [/SUP], Nick Ruktanonchai[SUP] 3 19 [/SUP], Henrik Salje[SUP] 5 [/SUP], Kathryn L Schaber[SUP] 2 [/SUP], Andrew J Tatem[SUP] 3 [/SUP], Jasmine Wang[SUP] 2 [/SUP], Derek A T Cummings[SUP] 6 8 [/SUP], Amy Wesolowski[SUP] 2 [/SUP]



Affiliations
Abstract

The emergence of SARS-CoV-2 into a highly susceptible global population was primarily driven by human mobility-induced introduction events. Especially in the early stages, understanding mobility was vital to mitigating the pandemic prior to widespread vaccine availability. We conducted a systematic review of studies published from January 1, 2020, to May 9, 2021, that used population-level human mobility data to understand SARS-CoV-2 transmission. Of the 5505 papers with abstracts screened, 232 were included in the analysis. These papers focused on a range of specific questions but were dominated by analyses focusing on the USA and China. The majority included mobile phone data, followed by Google Community Mobility Reports, and few included any adjustments to account for potential biases in population sampling processes. There was no clear relationship between methods used to integrate mobility and SARS-CoV-2 data and goals of analysis. When considering papers focused only on the estimation of the effective reproductive number within the US, there was no clear relationship identified between this measure and changes in mobility patterns. Our findings underscore the need for standardized, systematic ways to identify the source of mobility data, select an appropriate approach to using it in analysis, and reporting.


 
Back
Top Bottom